ライフサイエンスコーパス: negative group

1 vidence of endoleak or aneurysm enlargement (negative group).

2 ats (14 eyes) were kept in room air (control negative group).

3 with no family history of alcoholism (family-negative group).

4 x was reduced by 30% at 2 weeks in the HER-2-negative group.

5 as stronger in the apolipoprotein E epsilon4-negative group.

6 (iii) two nitrogen groups combined with one negative group.

7 ing from bone cancer pain and animals in the negative group.

8 oup, compared with the Pittsburgh compound B negative group.

9 documentation of 34 events in the early PET-negative group.

10 ts but more by ROR in the HER2-negative/node-negative group.

11 e group (P = 0.010) than in the autoantibody negative group.

12 the test-positive group, 1,636 into the test-negative group.

13 10.6 g/dL in both marrow-positive and marrow-negative groups.

14 ot differ between marrow-positive and marrow-negative groups.

15 e in survival between Jo-1 positive and Jo-1 negative groups.

16 e clinical features of the PCR-positive and -negative groups.

17 ent nitrogen groups as well as two different negative groups.

18 (OS) were compared between FH-positive and -negative groups.

19 ic differences between HCV RNA-positive and -negative groups.

20 different in the FXM-positive versus the FXM-negative groups.

21 lic events between the antibody-positive and-negative groups.

22 e donors (P = 0.01) but not by PBMC from DTH-negative groups.

23 y different between EBV DNAemia positive and negative groups.

24 ccording to PCR results into HD, TP, and PCR-negative groups.

25 f patients in the >/= 10% ER-positive and ER-negative groups.

26 ifference between the HER2-positive and HER2-negative groups.

27 te difference between antibody-positive and -negative groups.

28 tinct groups, triple-negative and non-triple-negative groups.

29 teristics between the HLA DR15-positive and -negative groups.

30 tive tumors in both the ALK-positive and ALK-negative groups.

31 lacebo group and compare them with an "Abeta-negative" group.

32 but reduced in the malaria positive and EVD negative group (0.37, 0.20-1.23, p=0.0010).

33 l [CI], 0.96 to 0.97; odds ratio in the SIRS-negative group, 0.96; 95% CI, 0.94 to 0.98; P=0.12 for b

34 ter (CL<200 ms) induced in 203 patients (EPS negative, group 1), monomorphic VT induced in 87 patient

35 Cardiac events in the three groups included: negative group, 1 non-Q-wave myocardial infarction (MI);

36 monale (HTLV-1-positive group, 10/52; HTLV-1-negative group, 1/37; P = .023) was more frequent among

37 Total mortality was lower in the TWA-negative group (10% vs. 18% at 2 years; p = 0.04).

38 egative/PCR-positive (21 mug/ml) and the GDH-negative groups (13 mug/ml).

39 16.9 months; P = .89) when compared with the negative group (16.2 months).

40 %, group 1), and the remaining patients were negative (group 2).

41 The HIV-negative, group 2 children had a mean radioaerosol clear

42 Conversely, in the ABCA4-negative group, 22 of 26 eyes (13 of 15 patients) had qA

43 e TERT-positive group compared with the TERT-negative group (3-year estimates, 21.4% +/- 9.5% v 63.7%

44 e TERT-positive group compared with the TERT-negative group (3-year estimates, 33.3% +/- 13.6% v 72.0

45 e TERT-positive group compared with the TERT-negative group (3-year estimates, 42.9% +/- 12.2% v 70.0

46 significantly higher than that of the fusion-negative group (35% +/- 8% vs 13% +/- 3%, P = .008) and

47 atients (82%) than in the bacterial antibody-negative group (38%).

48 ed 90% CI 24-47), and 21 of 54 in the IGF-1R-negative group (39%, one-sided 95% CI lower bound 28%; t

49 For the HR-negative group, 5-year OS rates were 83.9% v 67.4% (P =

50 tly lower for LOH-positive compared with LOH-negative groups (74% vs 87%, HR, 2.19; 95% CI, 1.25-3.83

51 epinephrine infusion was -23 ms in the gene-negative group, 78 ms in LQT1, -4 ms in LQT2, and -58 ms

52 positive group (57.5%) compared with the TRI-negative group (87.3%; P=0.002).

53 diagnosed by electron microscopy (EM) and a negative group A rotavirus enzyme-linked immunosorbent a

54 Among the immunostain negative group, all had hemizygous PTEN deletion but no

55 ed on how they described their experience; a negative group, an ambivalent group and a positive group

56 he 5-yr mark, survival is 100% in the GIV-fl-negative group and 62 +/- 9% (mean+/-SE; P=6x10(-5)) in

57 the M. fortuitum third biovariant D-sorbitol-negative group and porcine strains of M. porcinum and co

58 ified melanoma cells into MiTF-positive and -negative groups and explored the function of MiTF in reg

59 ey are (i) three nitrogen groups, (ii) three negative groups, and (iii) two nitrogen groups combined

60 tment groups and in the Apo E2-positive and -negative groups, and for a previously reported time-to-t

61 e (P<0.025), 23% of the focal, and 7% of the negative group at between one month and 15 years posttra

62 L between the genotype-positive and genotype-negative groups at baseline.

63 if the T1 screen had not been done in the T0 negative group, at most, an additional 28 participants i

64 observed in angiogram positive and angiogram negative groups compared to controls in a dominant analy

65 y higher in angiogram positive and angiogram negative groups compared to the control group (51.2 vs.

66 ted) from disease-negative (D-, or microbial-negative) groups: D+ and D- data distributions overlappe

67 The negative group described both past and present relations

68 ch of the antibiotic, placebo, and H. pylori-negative groups during the 12-month study period.

69 The median survival of PET-positive and -negative groups from the date of the scan was 20 and 30.

70 ts] to 18.3% [2037 of 11,119], P<0.001; SIRS-negative group: from 27.7% [100 of 361] to 9.3% [122 of

71 mong patients with adenocarcinoma, the ALDH1-negative group had shorter survival compared with the AL

72 The HIV-positive and HIV-negative groups had comparable median age (21 years) and

73 Both HGV-positive and -negative groups had similar survival, recurrence rates,

74 r in the chronic HB group compared to the HB-negative group (hazard ratio [HR], 1.80; 95% CI, 1.20-2.

75 Among the GCA-negative group, herpes zoster antigen was not detected i

76 ge 6 into Alternaria-positive and Alternaria-negative groups identifies subphenotypes that are furthe

77 or PFS between the HLA DR15-positive versus-negative groups in any disease or donor relation subgrou

78 e theory's view on the possible reduction of negative group interactions.

79 The saliva from the Aa-negative group killed Aa by two logs (P <0.05).

80 similar in the DSA-SPA-positive and DSA-SPA-negative groups (log-rank test=0.63, P=0.428).

81 similar in the DSA-SPA-positive and DSA-SPA-negative groups (log-rank test=0.63, P=0.428).

82 for both lymph node-positive and lymph node-negative groups may improve without any increase in over

83 urvival of 68% (50-81), whereas in the T790M-negative group, median progression-free survival was 10.

84 t survival (p < 0.001) compared with the PCR-negative group (n = 57, 25% graft loss at 8.7 years) and

85 S+] group; n = 6) or not (lipopolysaccharide-negative group; n = 6).

86 birth compared with 52.2% of infants in the negative group (odds ratio [OR], 3.86; 95% confidence in

87 is found largely within the clinical triple-negative group of breast cancer patients.

88 ve group of strains than for the ESBL screen-negative group of strains.

89 f the M. fortuitum third biovariant sorbitol-negative group, of which 48 (70%) had the same PCR restr

90 7) versus 0.07 (range, -0.21 to 0.18) in the negative group (P < .0001).

91 positive group compared with 26% in the pAkt-negative group (P = .0076).

92 l versus 14 (39%) of 36 patients in the FISH-negative group (P = .087).

93 mor recurrence compared with 2.9% in the Wnt-negative group (P = 0.02).

94 ined tumors from the RNA polymerase antibody-negative group (P = 0.048).

95 2, compared with 2.0 +/- 1.8 in the antibody-negative group (P = 0.59).

96 rriers than in the combined at-risk and gene-negative groups (P < 0.05).

97 i-U3 RNP (30%, versus 10% in the anti-U3 RNP-negative group; P < 0.001).

98 ody-positive group vs. 16.6% in the antibody-negative group; P = 0.019).

99 -positive group vs. 13 of 39 in the mutation-negative group; P=.004).

100 -positive group vs. 30 of 42 in the mutation-negative group; P=.014), coloboma of the eye (55 of 62 i

101 -positive group vs. 30 of 43 in the mutation-negative group; P=.022), and facial asymmetry, often cau

102 Compared with the ROS1-negative group, patients with ROS1 rearrangements were s

103 The negative group (PCa-) combined 24 biopsy negative (Bx-)

104 Patients in the DSA-SPA-positive and DSA-SPA-negative groups received similar immunosuppression, and

105 Patients in the DSA-SPA-positive and DSA-SPA-negative groups received similar immunosuppression, and

106 e between the genotype-positive and genotype-negative groups regarding age, smoking status, gender, W

107 The amyloid-positive neurodegeneration-negative group remained stable.

108 ere 22.3 and 13.3% for the HIV-positive and -negative groups, respectively (relative risk = 1.68, 95%

109 nsitivity in sputum smear-positive and smear-negative groups, respectively.

110 were performed on the node-positive and node-negative groups separately to ascertain the effect of ly

111 At 5 hours, the epsilon4-negative group showed significant improvement in long-te

112 ROS1-positive and -negative groups showed no difference in overall survival

113 However, the event rate in the TWA-negative group suggests that TWA may not be capable of i

114 For the ALK-negative group, the 5-year FFS was 46% for patients with

115 In the HER2-negative group, the size discrepancy was smaller for hor

116 common in the HER2-positive than in the HER2-negative group; the opposite pattern was seen for PTEN m

117 Comparing the HCV-positive versus HCV-negative groups, there were no significant differences w

118 ss: compared with individuals in the amyloid-negative group, those in the amyloid-positive group were

119 of 57 patients) and nine more in the IGF-1R-negative group (total of 63 patients).

120 Within the negative group, uniphasic/unenhanced, biphasic, and comp

121 ich has momentum intervals with positive and negative group velocities.

122 nkov radiation is predominantly emitted with negative group velocity and therefore propagates backwar

123 of modulated wave packets propagating with a negative group velocity in a passive artificial ADM in m

124 silk structure generates a unique region of negative group velocity, that together with the global (

125 ear to propagate with a superluminal or even negative group velocity.

126 In this work, we investigate the negative-group-velocity transmission of half-sine wave p

127 The median survival of PET-positive and PET-negative groups was 32.9 and 81.6 mo, respectively (P <

128 false-positive group compared with the true-negative group when mfERG was verified against AVF sugge

129 -positive group did not differ from the FISH-negative group with respect to age, sex, race, tumor gra

130 use history between the HIV-positive and HIV-negative groups with and without a history of alcohol ab

131 death after transplant compared with the HCV-negative group, with an aRR of 5.5 (95% CI, 1.5-20.0).

132 ost, an additional 28 participants in the T0 negative group would have died from lung cancer (a rise